This study is collecting information from people undergoing a standard hematopoietic stem cell transplant (a procedure that replaces damaged blood-forming cells with healthy ones). It's for individuals with certain blood cancers like Acute Myelogenous Leukemia or Non-Hodgkin's Lymphoma. The study isn't testing a new treatment, but rather observing the outcomes of standard care. We are looking for up to 2000 participants aged 18 to 120 years old who are planning to have either an allogeneic (from a donor) or autologous (using your own cells) bone marrow transplant. The main goal is to collect and analyze data for one year after your transplant to understand how well these standard treatments work.

Study design

This is an observational study, meaning it collects information without testing a specific intervention. It aims to include up to 2000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your data will be followed up for one year after the transplant.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.